Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Bioorg Med Chem. 2018 Aug 20;26(18):4984–4995. doi: 10.1016/j.bmc.2018.08.020

Table 4.

In-vitro biological evaluation of compounds derived by Scheme 4.

IC50 (nM)* Microsome stability (min)

Compd. R1 MMP-13 MMP-2 MMP-8 clogD7.4a clogPb rat mouse human Collagen cleavage
(20 μM)

2 graphic file with name nihms-1507852-t0054.jpg 2.7±0.6 >5000 >5000 4.2 3.0 9 20 12 >90%
52 graphic file with name nihms-1507852-t0055.jpg 7.1±0.8 >5000 1100±236 3.6 3.3 9 26 12 >90%
53 graphic file with name nihms-1507852-t0056.jpg >5000 nd nd 3.3 2.7 14 110 59 nd
54 graphic file with name nihms-1507852-t0057.jpg 18±4.9 nd nd 3.2 2.5 10 31 21 40%
55 graphic file with name nihms-1507852-t0058.jpg 38±7.5 >5000 >5000 3.3 1.5 4 12 96 65%
56 graphic file with name nihms-1507852-t0059.jpg 148±8.5 nd nd 3.8 3.3 5 20 82 nd
*

The IC50 values for MMP-1, MMP-9, and MT1-MMP are >5 μM for all compounds. nd = not determined.

a

Calculated with Pipeline Pilot workflow application (Accelrys) at pH 7.4.

b

Calculated with ChemDraw.